Publication & Citation Trends
Publications
0 total
Use of molecular NGS vs single gene testing differs by clinical setting and physician’s specialty in mNSCLC management.
Cited by 1
Semantic Scholar
Abstract MIP-055: IDENTIFICATION OF A MOLECULAR SUBTYPE OF HIGH GRADE SEROUS OVARIAN CANCER REPRESENTING MAPK PATHWAY ACTIVATION AND PLATINUM RESISTANCE
Cited by 0
Semantic Scholar
Abstract OT3-02-07: Neo-DDRD: A biomarker-driven neoadjuvant feasibility study in breast cancer
Cited by 1
Semantic Scholar
Abstract 453: MEK activation is associated with a molecular subgroup in high grade serous ovarian cancer
Cited by 0
Semantic Scholar
Prior knowledge transfer across transcriptional data sets and technologies using compositional statistics yields new mislabelled ovarian cell line OA
Cited by 24
Semantic Scholar
A biomarker-guided first-in-human trial of subcutaneous ALM201 in patients with solid tumours. OA
Cited by 0
Semantic Scholar
Abstract 626: Cross-site reproducibility and orthogonal validation of copy number and somatic mutation calls of OncoScan® FFPE Assay Kit in solid tumors
Cited by 0
Semantic Scholar
Research Topics
DNA Repair Mechanisms
(9)
Ion channel regulation and function
(7)
Cancer-related Molecular Pathways
(7)
Cardiac electrophysiology and arrhythmias
(4)
Lung Cancer Treatments and Mutations
(4)
Affiliations
Queen's University Belfast
Lurie Children's Hospital
Babraham Institute
QIMR Berghofer Medical Research Institute
University College Cork